Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Combining ciclosporin and simvastatin can cause severe kidney damage.

Inclisiran is effective at lowering cholesterol.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Vogt-Koyanagi-Harada disease can develop during interferon therapy for chronic hepatitis C.

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Ivacaftor can protect against noise-induced hearing loss by reducing oxidative stress.

Baricitinib effectively regrew hair in a woman with alopecia universalis after other treatments failed.

Valproic acid is an effective seizure medication with some temporary side effects.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

Long-term high-dose fluconazole can cause reversible hair loss.

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.